news
Utilising electric car batteries for safer and cheaper medicine manufacture
A method commonly used in lithium-ion batteries has been developed to help the safer and cheaper manufacture of medicines...
List view / Grid view
Manufacturing
news
EU measures in support of generic pharmaceuticals producers
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
news
‘Smart drug’ shows promise for metastatic triple-negative breast cancer
A study has shown that a 'smart drug' that delivers a toxic payload directly to tumour cells could be a possible treatment for breast cancer...
news
Sales of generic oncology drugs surge
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
news
Structural barriers biggest reason for low participation in clinical trials
A study has shown how structural barriers are one of the main reasons why clinical trials often do not meet their enrolment targets...
whitepaper
Flyer: Biologicals drug substance and drug product
Eurofins CDMO provides a full suite of drug development services encompassing development of the bioprocesses, formulation screening, analytical development, pre-clinical testing, sterile and non-sterile bio-manufacturing of clinical trial batches and orphan drugs.
news
Inadequate FDA oversight concerning fentanyl prescriptions
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
news
Oral antifungals used to treat yeast infections could lead to miscarriage
Researchers have found that fluconazole used to treat yeast infections in pregnant women could cause a higher risk of miscarriage...
news
Perigord announces the release of GLAMS CMO
Simplify your artwork process, get closer to your customers and strengthen compliance...
news
Biotech firm awarded for approach to drug development
A UK based biotech firm has been awarded a grant to develop a treatment for osteoarthritis, after promising results from a Phase I trial...
news
Policy to improve access and foster price competition for generics
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
news
Draft guidance on CDER’s program to recognise standards in pharmaceutical quality
Draft guidance has been released to offer advice on the new CDER program for the recognition of voluntary consensus standards relating to pharma quality...
news
Programs to promote innovations in drug manufacturing
Innovations in drug manufacturing could result in higher quality drugs at less of the cost, and the FDA is willing to help facilitate this development...
news
SMC accepts restricted use of rivaroxaban for CAD
The SMC has approved a drug, called rivaroxaban, that targets Factor Xa to treat those with coronary artery disease (CAD)...
news
Phase III clinical trial for treatment of dry eye syndrome
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...
